| Joyce Dejong, DO | |
|
1322 E Michigan Ave, Suite 118, Lansing, MI 48912-2199 | |
| (517) 364-2578 | |
| Not Available |
| Full Name | Joyce Dejong |
|---|---|
| Gender | Female |
| Speciality | Pathology - Forensic Pathology |
| Location | 1322 E Michigan Ave, Lansing, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760610455 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZF0201X | Pathology - Forensic Pathology | 5101010300 (Michigan) | Primary |
| 207ZP0101X | Pathology - Anatomic Pathology | 5101010300 (Michigan) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Joyce Dejong, DO 1322 E Michigan Ave, Suite 118, Lansing, MI 48912-2199 Ph: (517) 364-2578 | Joyce Dejong, DO 1322 E Michigan Ave, Suite 118, Lansing, MI 48912-2199 Ph: (517) 364-2578 |
News Archive
Pharmacyclics, Inc. today announced that the U.S. Food and Drug Administration has accepted for filing its supplemental New Drug Application (sNDA) to support the review of IMBRUVICA (ibrutinib) in the treatment of patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) who have received at least one prior therapy for a full approval.
Scientists from the Helmholtz Zentrum Muenchen and the Technische Universitaet Muenchen, together with scientists in the USA, have developed a new therapeutic approach for treatment of Type 2 diabetes. A novel single molecule hormone, which acts equally on the receptors of the insulin-stimulating hormones GLP-1 and GIP, was observed to reduce weight and improve blood sugar.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that it is operating a strategic review that should result in the outsourcing of all existing and future clinical and commercial manufacturing operations to contract manufacturing organizations (CMOs).
In an article appearing in Medical Hypotheses on September 20, a New York-based physician-researcher from the Touro College of Osteopathic Medicine has called for the testing of umbilical cord blood for levels of a growth protein that could help predict an infant's propensity to later develop autism.
More focus should be placed on relieving the most bothersome or "core" symptom for patients with benign prostatic hyperplasia, report Korean researchers.
› Verified 6 days ago
Maria B Costa-fox, MD Pathology Medicare: Medicare Enrolled Practice Location: 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-364-1000 Fax: 517-483-2837 | |
Ying Qin, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1215 E Michigan Ave, Sparrow Hospital, Lansing, MI 48912 Phone: 517-332-5050 Fax: 517-332-8011 | |
Reuben V Cuison, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1215 E Michigan Avenue, Capital Pathology Pc, Lansing, MI 48912 Phone: 517-364-1000 Fax: 517-372-0581 | |
Mehboob Mohammed Sarlique Fatteh, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 W Greenlawn Ave, Lansing, MI 48910 Phone: 810-733-7741 | |
Bashar Sharaf Aldeen, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 W Greenlawn Ave, Lansing, MI 48910 Phone: 517-334-2472 Fax: 517-334-2259 | |
Neil Chase Caliman, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2508 South Cedar, Lansing, MI 48910 Phone: 517-372-5520 Fax: 617-372-5540 | |
Dr. Richard Arthur Simms, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 7115 Ravenna Trl, Lansing, MI 48917 Phone: 517-327-0906 |